Antipsychotic nonadherence is an important barrier to the successful treatment of
schizophrenia and can lead to clinical and economic burdens. Interventions capable of …

OBJECTIVE: Although nonadherence with the antipsychotic medication regimen is a
common barrier to the effective treatment for schizophrenia, knowledge is limited about how …

For individuals who have schizophrenia, adherence to medication is often poor, and
stopping medication often has serious consequences. This article provides an update on …

ObjectiveNonadherence to antipsychotic medication is highly prevalent in patients with
schizophrenia and has a deleterious impact on the course of the illness. This review seeks …

Objective: To review the consequences of nonadherence to antipsychotic pharmacotherapy
in patients with schizophrenia, as well as associated risk factors for nonadherence and …

Adherence to antipsychotics improves outcome in schizophrenia. There is a lack of
consensus on which factors most influence adherence behaviour and methodological …

Nonadherence with medication treatment is common but difficult to detect in patients with
schizoaffective disorder and schizophrenia, almost half of whom take less than 70% of …

Nonadherence to medications is very common in people with schizophrenia. Numerous
methods have been implemented to improve medication adherence. The study aimed to …

Medication nonadherence is common among patients with schizophrenia and due to a
variety of factors including lack of insight, psychopathology, substance use disorder, issues …

Nonadherence with medication occurs in all chronic medical disorders. It is a particular
challenge in schizophrenia due to the illness's association with social isolation, stigma, and …